Search

everythinglearnresearchcommunity

for

Search:↓

Low iron levels are significantly linked to hair loss in women.

Both minoxidil-spironolactone and minoxidil-finasteride treatments work for hair loss, but minoxidil-spironolactone is slightly more effective, especially in women.

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Hormonal therapy like cyproterone acetate and spironolactone may help female hair loss, but more research is needed, especially for pre-menopausal women.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Some nonsurgical hair loss treatments are effective, especially if started early.

Iron deficiency might be linked to hair loss, but more research is needed.

Finasteride for female hair loss has low side effects, more research needed.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

A postmenopausal woman with hair loss and hirsutism improved after surgery to remove an ovarian tumor.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Trichoscopy is useful for correctly diagnosing tinea capitis in adults with unexplained hair loss.

Long-term estrogen therapy in postmenopausal women can improve certain health markers, hair loss is common regardless of hormone use, stopping estrogen doesn't increase breast cancer risk, smoking does, and a balanced BMI is linked to lower mortality.

Low iron levels are strongly linked to chronic hair loss in women.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.

Children receive less than half of recommended health care, and routine hormonal testing for female-pattern hair loss is unnecessary without other androgen excess symptoms.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Fibrosing alopecia in a pattern distribution is a hair loss condition often confused with other types, requiring early treatment but usually not resulting in significant hair regrowth.

French maritime pine bark extract significantly increased hair density in menopausal women.

Minoxidil effectively treats hair loss, but use cautiously and monitor side effects.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.

Topical steroids help Erosive Lichen Planus, finasteride with birth control aids Female Pattern Hair Loss, young age helps Occupational Hand Eczema prognosis, quitting smoking is key for Diffuse Dermal Angiomatosis, and a 3-site Botulinum Toxin A injection is effective for glabellar wrinkles.

Most Indian people with hair loss in the study lacked nutrients, especially iron.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.